The Patent Finder

Neurovision Pharma GmbH

Also on record
Records under this name other than the patents Neurovision Pharma GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 5 of 5 · Back to Neurovision Pharma GmbH

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,785,601Methods of treating neurological conditions with hematopoietic growth factors
Lapsed on the fee record
Ended Aug 31, 2022 · USPTO record
Lapsed on the fee recordEnded Aug 31, 2022USPTO record
US 8,071,543Methods of treating neurological conditions with hematopoeitic growth factors
Lapsed on the fee record
Ended Dec 6, 2019 · USPTO record
Lapsed on the fee recordEnded Dec 6, 2019USPTO record
US 8,053,407Methods of treating neurological conditions with hematopoeitic growth factors
Lapsed on the fee record
Ended Nov 8, 2019 · USPTO record
Lapsed on the fee recordEnded Nov 8, 2019USPTO record
US 7,884,069Methods of treating neurological conditions with hematopoeitic growth factors
Lapsed on the fee record
Ended Feb 8, 2019 · USPTO record
Lapsed on the fee recordEnded Feb 8, 2019USPTO record
US 7,695,723Methods of treating neurological conditions with hematopoietic growth factors
Lapsed on the fee record
Ended Apr 13, 2018 · USPTO record
Lapsed on the fee recordEnded Apr 13, 2018USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited